Risks related to regulatory changes under the Act on Pharmaceuticals and Medical Devices and other laws, and permit revocation
First written in FY2016. 8 of 10 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company continues to describe the risk of business restrictions resulting from the renewal of permits under the Pharmaceuticals and Medical Devices Act, violations of laws and regulations, revocation of permits and regulatory changes. - FY2023WorsenedAnnual report
「In our e-commerce business, we sell products over the internet and are subject to regulations including the Specified Commercial Transactions Act. If new legal regulations targeting internet users and related businesses are introduced in the future, and our e-commerce business becomes subject to any restrictions under those laws, or if laws and regulations are unexpectedly amended or newly introduced, our Group's business activities may be restricted, adversely affecting our operating results and financial position.」
In addition to existing cosmetics-related regulations, the company explicitly identifies the risk of business restrictions arising from current regulations including the Specified Commercial Transactions Act applicable to its e-commerce business, as well as from the enactment or amendment of laws and regulations in the future. - FY2022RestatedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company reiterates the risk of business restrictions resulting from the renewal of permits under the Pharmaceuticals and Medical Devices Act, changes in regulations, and revocation of permits. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes concerning the risk of regulatory changes under the Pharmaceuticals and Medical Devices Act and other laws or revocation of permits. - FY2021-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes concerning the risk of regulatory changes under the Pharmaceuticals and Medical Devices Act and other laws or revocation of permits. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no newly arising risks or material changes to matters described in the previous fiscal year concerning business and other risks. - FY2019RestatedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company reiterates the risk of business restrictions resulting from the renewal of permits under the Pharmaceuticals and Medical Devices Act, changes in regulations, and revocation of permits. - FY2018RestatedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company reiterates the risk of business restrictions resulting from the renewal of permits under the Pharmaceuticals and Medical Devices Act, changes in laws and regulations, and revocation of permits. - FY2017RestatedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company reiterates the risks of business restrictions resulting from the 5-year renewal of permits under the Pharmaceuticals and Medical Devices Act, changes in laws and regulations, and revocation of permits. - FY2016First statedAnnual report
「This permit is renewed every 5 years, along with the completion of other necessary procedures.」
The company identifies the 5-year renewal of the permit and business restrictions resulting from violations of laws and regulations or revocation of the permit as risks.